PENELOPE
Prevalence of unmet target LDL-C recommendations in very high risk patients despite high intensity lipid modifying therapy
- Stage
- klaar
- Medicine
- Niet van toepassing
- Population
- ASCVD
- Phase
- IV
- First Patient In
- 15 January 2019
- Last Patient In
- 26 August 2020
- Last Patient Last Visit
- 28 February 2022
Study Director
dr. A.M.W. Alings
Cardioloog
Office Contact
